Specifically, the increased expression of the olfactory receptor OR2L13 (Olfr166; Olfr168) was identified as a feature of platelets that are biomechanically activated by an increase in blood flow turbulence in AAA patients. This evidence concerns the gene OR2L13 and triple-A syndrome.